Industry Insights
Cost-saving strategies for Pharmacy Benefits Managers.
Industry Insight
Industry Insight
Jun 01, 2026
Reducing Diabetes Drug Cost
Reducing Diabetes Drug Cost Trend Growth by ~40% With a Lowest Net Cost Approach
Industry Insight
Industry Insight
Apr 07, 2026
Advancing Inflammatory Biosimilars
How Scripius Uses Biosimilar Adoption as Part of Its Lowest Net Cost Strategy
Industry Insight
Industry Insight
Feb 06, 2026
PBM Reform
Scripius' perspective on the passage of Pharmacy Benefit Manager (PBM) reform legislation.
Industry Insight
Industry Insight
May 27, 2025
Biosimilar Savings
Scripius is poised to make a decisive move by removing Stelara from our standard Large Employer formularies as of July 1, 2025.
Industry Insight
Industry Insight
Nov 04, 2024
Controlling Costs in 2025
Scripius' 2024 drug coverage changes aim to reduce costs for diabetes and arthritis meds in 2025.
Industry Insight
Industry Insight
Jul 31, 2024
Adopting Biosimilars
Strategies and insights on adopting biosimilars, featuring expert Matt Mitchell.
Industry Insight
Industry Insight
Apr 04, 2024
Creating RX Savings
Scripius' 2023 drug coverage changes aim to cut costs and improve access in 2024.
Industry Insight
Industry Insight
Oct 03, 2023
GLP-1 Utilization
If it doesn’t have one already, your health plan needs a GLP-1 strategy.
Industry Insight
Industry Insight
Aug 10, 2023
Quarters 1 & 2 (2023) Market Update
Scripius' quick Rx market actions save money and improve drug access.
Sign up for the Scripius Industry Insights newsletter
Get timely industry insights, PBM perspectives, and cost-saving strategies delivered to your inbox.
